TELA Bio, Inc. (TELA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 30M 60M 90M Q2 '19: 11.2M Q3 '19: 13M Q4 '19: 15.4M Q1 '20: 15.9M Q2 '20: 16.1M Q3 '20: 17.4M Q4 '20: 18.2M Q1 '21: 20.4M Q2 '21: 24.4M Q3 '21: 26.8M Q4 '21: 29.5M Q1 '22: 31.8M Q2 '22: 34.7M Q3 '22: 38.2M Q4 '22: 41.4M Q1 '23: 45.1M Q2 '23: 49.2M Q3 '23: 53.1M Q4 '23: 58.5M Q1 '24: 63.1M Q2 '24: 64.7M Q3 '24: 68.6M Q4 '24: 69.3M Q1 '25: 71.2M Q2 '25: 75.3M Q3 '25: 77.1M Q4 '25: 80.3M Q1 '26: 80.8M Q2 '26: 79.9M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Gross Profit TTM

0 20M 40M 60M Q2 '19: 6.1M Q3 '19: 7.3M Q4 '19: 9.3M Q1 '20: 9.7M Q2 '20: 9.9M Q3 '20: 10.5M Q4 '20: 11.2M Q1 '21: 12.5M Q2 '21: 15.5M Q3 '21: 16.8M Q4 '21: 18.8M Q1 '22: 20.3M Q2 '22: 21.8M Q3 '22: 24.5M Q4 '22: 27M Q1 '23: 29.9M Q2 '23: 33.6M Q3 '23: 36.7M Q4 '23: 40.1M Q1 '24: 43.5M Q2 '24: 44.4M Q3 '24: 46.9M Q4 '24: 46.5M Q1 '25: 47.7M Q2 '25: 50.7M Q3 '25: 51.8M Q4 '25: 54.3M Q1 '26: 54.3M Q2 '26: 54.2M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Income TTM

-45M -30M -15M 0 15M 30M 45M Q2 '19: -17.5M Q3 '19: -18.8M Q4 '19: -19.2M Q1 '20: -20.5M Q2 '20: -21.3M Q3 '20: -24.4M Q4 '20: -25.3M Q1 '21: -26M Q2 '21: -28.2M Q3 '21: -28.5M Q4 '21: -29.5M Q1 '22: -32M Q2 '22: -35M Q3 '22: -37.2M Q4 '22: -39M Q1 '23: -40.4M Q2 '23: -40.5M Q3 '23: -41.2M Q4 '23: -44.1M Q1 '24: -37.6M Q2 '24: -38.9M Q3 '24: -38M Q4 '24: -34.1M Q1 '25: -39.8M Q2 '25: -37.3M Q3 '25: -35.5M Q4 '25: -33.8M Q1 '26: -33.8M Q2 '26: -34M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Net Income TTM

-60M -40M -20M 0 20M 40M 60M Q2 '19: -21.4M Q3 '19: -23.3M Q4 '19: -22.4M Q1 '20: -23.7M Q2 '20: -24.5M Q3 '20: -27.5M Q4 '20: -28.8M Q1 '21: -29.7M Q2 '21: -31.9M Q3 '21: -32.4M Q4 '21: -33.3M Q1 '22: -36M Q2 '22: -40.5M Q3 '22: -42.9M Q4 '22: -44.3M Q1 '23: -45.5M Q2 '23: -43.5M Q3 '23: -43.8M Q4 '23: -46.7M Q1 '24: -40.3M Q2 '24: -42.1M Q3 '24: -41.5M Q4 '24: -37.8M Q1 '25: -43.4M Q2 '25: -40.8M Q3 '25: -39M Q4 '25: -38.8M Q1 '26: -39.8M Q2 '26: -41.2M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Cost of Revenue TTM

0 9M 18M 27M Q2 '19: 4.8M Q3 '19: 5.4M Q4 '19: 5.9M Q1 '20: 5.9M Q2 '20: 5.9M Q3 '20: 6.6M Q4 '20: 6.7M Q1 '21: 7.6M Q2 '21: 8.6M Q3 '21: 9.6M Q4 '21: 10.3M Q1 '22: 11.2M Q2 '22: 12.1M Q3 '22: 12.9M Q4 '22: 13.6M Q1 '23: 14.3M Q2 '23: 15.2M Q3 '23: 16M Q4 '23: 18M Q1 '24: 19.2M Q2 '24: 19.9M Q3 '24: 21.4M Q4 '24: 22.4M Q1 '25: 23.2M Q2 '25: 24.2M Q3 '25: 24.9M Q4 '25: 25.6M Q1 '26: 26.1M Q2 '26: 25.3M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q3 '19: -24.1M Q4 '19: -25.5M Q1 '20: -25.1M Q2 '20: -26.2M Q3 '20: -24.5M Q4 '20: -24.5M Q1 '21: -25.7M Q2 '21: -25M Q3 '21: -27.9M Q4 '21: -30.4M Q1 '22: -32.3M Q2 '22: -38.3M Q3 '22: -39.4M Q4 '22: -40.7M Q1 '23: -41.9M Q2 '23: -41.5M Q3 '23: -40.8M Q4 '23: -40.9M Q1 '24: -43.7M Q2 '24: -43.1M Q3 '24: -45.1M Q4 '24: -41.6M Q1 '25: -36.9M Q2 '25: -34.1M Q3 '25: -30.9M Q4 '25: -28.2M Q1 '26: -29.7M Q2 '26: -31.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Free Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q3 '19: -24.3M Q4 '19: -25.7M Q1 '20: -25.3M Q2 '20: -26.4M Q3 '20: -24.7M Q4 '20: -24.6M Q1 '21: -25.9M Q2 '21: -25.1M Q3 '21: -28.3M Q4 '21: -31.1M Q1 '22: -33.2M Q2 '22: -39.5M Q3 '22: -40.5M Q4 '22: -41.6M Q1 '23: -42.5M Q2 '23: -42.1M Q3 '23: -41.2M Q4 '23: -41.5M Q1 '24: -44.5M Q2 '24: -44M Q3 '24: -46M Q4 '24: -42.6M Q1 '25: -37.7M Q2 '25: -34.7M Q3 '25: -31.5M Q4 '25: -28.7M Q1 '26: -30.2M Q2 '26: -31.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '21: 14.4M Q2 '21: 14.5M Q3 '21: 14.5M Q1 '22: 14.5M Q2 '22: 14.6M Q3 '22: 16.8M Q1 '23: 19.2M Q2 '23: 23.2M Q3 '23: 24.5M Q1 '24: 24.6M Q2 '24: 24.7M Q3 '24: 24.7M Q1 '25: 45.3M Q2 '25: 45.4M Q3 '25: 45.4M Q1 '26: 57.3M Q2 '26: 57.4M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q4 '20: -2.23 Q1 '21: -2.16 Q2 '21: -2.20 Q3 '21: -2.24 Q4 '21: -2.29 Q1 '22: -2.48 Q2 '22: -2.79 Q3 '22: -2.86 Q4 '22: -2.75 Q1 '23: -2.63 Q2 '23: -2.21 Q3 '23: -2.02 Q4 '23: -2.07 Q1 '24: -1.67 Q2 '24: -1.72 Q3 '24: -1.69 Q4 '24: -1.33 Q1 '25: -1.35 Q2 '25: -1.06 Q3 '25: -0.83 Q4 '25: -0.83 Q1 '26: -0.79 Q2 '26: -0.77 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.